---
title: "Raffles Medical Group Ltd (BSL.SG)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/BSL.SG.md"
symbol: "BSL.SG"
name: "Raffles Medical Group Ltd"
industry: "医疗机构"
---

# Raffles Medical Group Ltd (BSL.SG)

| Item | Detail |
|------|--------|
| Industry | 医疗机构 |
| Location | 新加坡市场 |
| Website | [www.rafflesmedicalgroup.com](https://www.rafflesmedicalgroup.com) |

## Company Profile

莱佛士医疗集团有限公司主要在新加坡、大中华区、越南、柬埔寨和日本提供综合私人医疗服务。该公司通过四个部门运营：医疗服务、医院服务、投资控股和保险服务。其莱佛士医院是一家提供 24 小时急性和重症护理、家庭医学服务、健康筛查以及多学科专科诊所的一所三级医院；设有病房、日间手术、血管造影室、分娩室、手术室、重症监护室和新生儿重症监护室；并提供放射学、临床实验室、药房、营养学、康复、传统中医、牙科服务和急救服务。该公司还交易药品和营养保健产品，以及诊断设备；并提供管理和咨询服务

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-20T04:30:12.000Z

**Overall: B (0.38)**

**Industry**: Health Care Facilities

| Metric | Value |
|--------|-------|
| Industry Ranking | 3 / 8 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 8.85% |  |
| Net Profit YoY | 4.54% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 1.86 |  |
| Dividend Ratio | 2.43% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1.90B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 765.64M |  |


**Multi Score**: B

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 6.26% | C |
| Profit Margin | 8.33% | B |
| Gross Margin | 45.95% | B |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 8.85% | B |
| Net Profit YoY | 4.54% | C |
| Total Assets YoY | -1.84% | D |
| Net Assets YoY | 0.35% | C |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 1201.05% | B |
| OCF YoY | 8.85% | B |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.51 | C |

#### Debt Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 30.55% | B |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Raffles Medical Group Ltd",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "6.26%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "8.33%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "45.95%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "8.85%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "4.54%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "-1.84%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "0.35%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "1201.05%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "8.85%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.51",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "B",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "30.55%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | BDMS TH SDR 1to2 (SG.TBDD) | B | C | B | B | B | B |
| 02 | IHH医疗保健 (SG.Q0F) | B | B | C | C | B | B |
| 03 | 莱佛士医疗 (SG.BSL) | B | C | C | B | B | B |
| 04 | 国际眼科中心 (SG.40T) | B | B | B | B | B | B |
| 05 | Econ Healthcare Asia (SG.EHG) | B | A | B | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 29.46 | 2/7 | 29.74 | 29.27 | 28.74 |
| PB | 1.84 | 3/7 | 1.83 | 1.80 | 1.75 |
| PS (TTM) | 2.45 | 2/7 | 2.46 | 2.44 | 2.39 |
| Dividend Yield | 2.45% | 1/7 | 2.54% | 2.48% | 2.43% |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-22T16:00:00.000Z

Total Analysts: **6**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 4 | 67% |
| Overweight | 1 | 17% |
| Hold | 1 | 17% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.02 |
| Highest Target | 1.32 |
| Lowest Target | 1.02 |

## References

- [Company Overview](https://longbridge.com/en/quote/BSL.SG/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/BSL.SG/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/BSL.SG/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.